Buy Haldol pills over the counter in online pharmacy

| Product Name | Haldol (Haldol) |
| Dosage | 0.5 mg, 1 mg, 2 mg, 5 mg, 10 mg, 20 mg tablets; 2 mg/mL oral solution; 5 mg/mL IM injection; 50 mg/mL and 100 mg/mL decanoate (LAI) |
| Active Ingredient | Haloperidol |
| Form | Oral tablets (also available as oral solution, short-acting IM, and long-acting IM decanoate) |
| Description | Typical antipsychotic for schizophrenia, acute psychosis, severe agitation, and tics in Tourette syndrome. Prescription-only in the United States. |
| How to Order Without Prescription | Not applicable in the U.S.; a valid prescription from a licensed clinician is required. |
Haldol (haloperidol) is one of the most established antipsychotic medicines used in the United States. It has been prescribed for decades to help manage symptoms of schizophrenia, acute psychosis, and severe agitation. It is also used to control motor and vocal tics associated with Tourette syndrome when other treatments are ineffective. In the U.S., Haldol is available only by prescription from a licensed healthcare professional. Commonly supplied dosage forms include oral tablets, an oral concentrate for flexible dosing, a short-acting intramuscular (IM) formulation for rapid control of agitation, and a long-acting haloperidol decanoate injection given at extended intervals to support maintenance therapy.
Because the therapy requires careful individualization, Haldol should be started and adjusted by a clinician who can monitor for efficacy and safety. U.S. guidelines emphasize using the lowest effective dose for the shortest duration necessary, regularly reassessing the benefit–risk balance, especially in long-term treatment. Below you’ll find a comprehensive guide to indications, dosing strategies, safety warnings, side effects, and practical tips for U.S. patients and caregivers considering haloperidol as part of a treatment plan.
Haldol price and access in the United States
In the U.S., cost varies by formulation (tablet, oral solution, immediate-acting IM, long-acting decanoate IM), dosage strength, brand vs. generic haloperidol, and your insurance coverage. Generic haloperidol tablets (for example, 0.5 mg to 10 mg strengths) are typically substantially less expensive than brand-name Haldol. Many community pharmacies and major retail chains offer competitive pricing for common strengths, and patient discount programs or manufacturer coupons may further reduce out-of-pocket expenses.
As a general orientation (not a guarantee of price), generic haloperidol tablets are often available at relatively low per-tablet cost, while long-acting decanoate injections can be more expensive due to the specialized formulation and clinic administration. Insurance plans in the U.S. commonly cover generic haloperidol with standard copays, whereas coverage for the decanoate injection depends on your plan’s medical vs. pharmacy benefit and prior authorization requirements. Always verify real-time pricing with your pharmacy, as costs change by location and insurer. Your prescriber or pharmacist can also advise on therapeutically equivalent strengths that may be more affordable based on inventory and plan formularies.
Important: because haloperidol is prescription-only in the United States, you will need a valid prescription to purchase it from any U.S. pharmacy or to receive it through mail-order services. Telemedicine appointments in many states allow evaluation and prescription if clinically appropriate.
Where can I buy Haldol in the USA?
If your clinician has prescribed haloperidol, you can fill your prescription at local community pharmacies, large retail chain pharmacies, hospital outpatient pharmacies, or licensed mail-order services that ship medications directly to your home. Many U.S. patients use mail-order for maintenance therapy to ensure consistent supply, especially for long-term use in schizophrenia.
Telehealth platforms operating within the U.S. may connect you with board-certified clinicians who can evaluate your symptoms and determine whether Haldol is appropriate. If prescribed, you can choose a pharmacy for dispensing. Always ensure the service is licensed in your state, and only obtain medications from state-licensed U.S. pharmacies. Purchasing prescription medicines without a valid prescription or from unverified sources is unsafe and illegal in the United States.
If you have concerns about cost or access, talk to your prescriber or pharmacist about generic haloperidol, coupon programs, 90-day mail-order supplies, or prior authorization paperwork to improve affordability and continuity of care.
Getting started with haloperidol
The process typically includes a mental health evaluation, review of prior treatments, screening for cardiac risk (e.g., a baseline ECG if risk factors are present), and a discussion of potential benefits and risks, including extrapyramidal symptoms (EPS) and tardive dyskinesia (TD). Your clinician will establish a dosing plan and follow-up schedule to track response and side effects.
What is haloperidol (Haldol)?
Haloperidol is a first-generation (typical) antipsychotic that primarily blocks dopamine D2 receptors in the brain. By reducing dopaminergic overactivity in key pathways, haloperidol helps alleviate positive symptoms of schizophrenia such as hallucinations, delusions, and disorganized thinking. It is also effective in rapidly controlling severe agitation and can suppress motor and vocal tics in Tourette syndrome when other therapies have not worked or are not tolerated.
In the U.S., Haldol is available as immediate-release oral tablets, an oral solution (commonly 2 mg/mL), a short-acting IM injection (5 mg/mL) used for acute agitation, and a long-acting depot preparation, haloperidol decanoate (50 mg/mL and 100 mg/mL), administered as a deep intramuscular injection typically every 4 weeks for maintenance therapy.
How Haldol works
Haloperidol’s main mechanism is antagonism at dopamine D2 receptors. In mesolimbic brain pathways, this reduces dopaminergic signaling that contributes to psychotic symptoms. However, D2 blockade in the nigrostriatal pathway can lead to EPS such as stiffness, tremor, akathisia, and dystonia. With chronic use, TD may develop in some patients. D2 antagonism in the tuberoinfundibular pathway may elevate prolactin, potentially causing menstrual changes, galactorrhea, or sexual dysfunction.
Haloperidol has minimal anticholinergic or antihistaminic activity relative to some other antipsychotics; this contributes to a lower risk of weight gain and metabolic side effects compared with many atypical agents, but may increase the likelihood of EPS. Haloperidol also carries a known risk for QT interval prolongation, which can precipitate torsades de pointes in susceptible patients. Careful risk assessment, ECG monitoring when warranted, and avoidance of interacting drugs help mitigate cardiac risk.
Indications and appropriate use
U.S.-approved uses include:
- Schizophrenia and related psychotic disorders
- Acute agitation and severe behavioral disturbance associated with psychosis
- Tourette syndrome (to suppress severe motor and vocal tics when other treatments fail)
Common off-label uses, based on clinician judgment and guidelines, may include refractory hiccups and palliative care nausea, though evidence and recommendations vary. For agitation or delirium in medically ill or older adults, clinicians often prefer nonpharmacologic strategies first and use antipsychotics cautiously and at the lowest effective dose when needed.
Dosage forms and strengths in the U.S.
The following formulations are commonly available in the U.S. (specific strengths and brands can vary by manufacturer):
- Oral tablets: 0.5 mg, 1 mg, 2 mg, 5 mg, 10 mg, 20 mg
- Oral solution (concentrate): 2 mg/mL (dropper bottle for titration)
- Short-acting IM injection: 5 mg/mL (for rapid control of severe agitation)
- Long-acting decanoate IM injection: 50 mg/mL and 100 mg/mL (maintenance therapy)
Note: Doses must be individualized. Use the lowest dose that controls symptoms and reassess regularly.
Adult dosing guide (U.S.)
Always follow your prescriber’s instructions. Typical ranges are summarized here for educational purposes:
Schizophrenia and psychosis (oral)
For adults new to antipsychotics, many clinicians begin with 0.5–2 mg two to three times daily, titrating in small increments to a usual total daily dose of 2–10 mg depending on response and tolerability. Some patients with severe symptoms may require higher doses, but exceeding 20 mg/day increases the risk of adverse effects without reliably improving outcomes. After stabilization, once-daily dosing may be possible, especially with sedating evening doses.
Acute agitation (IM short-acting)
For rapid control of severe agitation associated with psychosis, 2–5 mg IM may be administered, with cautious repeat dosing every 30–60 minutes as needed, up to typical maximums per institutional protocol. Monitor for oversedation, respiratory status, and EPS. Co-administration with a benzodiazepine may be used in specific settings with close monitoring and clinician oversight.
Long-acting haloperidol decanoate (IM)
Decanoate dosing is commonly initiated at 10–20 times the previous total daily oral dose, given as a single monthly injection or split into two injections over the first month to evaluate tolerability. Overlap with oral haloperidol is often recommended for the first 1–2 weeks until plasma levels from the depot are therapeutic. Maintenance dosing is individualized (e.g., 50–200 mg every 4 weeks), titrated based on symptom control and side effects. Deep-gluteal IM technique is required; aspiration prior to injection is recommended per product labeling.
Dose adjustments
Use lower starting doses and slower titration in older adults, those with hepatic impairment, or patients at increased risk for QT prolongation. If strong CYP3A4 or CYP2D6 inhibitors are added (e.g., clarithromycin, ketoconazole, fluoxetine, paroxetine), your clinician may reduce the haloperidol dose and increase ECG monitoring. If an enzyme inducer such as carbamazepine or rifampin is started, higher haloperidol doses may be required; however, drug combinations should be approached carefully and only under medical supervision.
Pediatric considerations
Haloperidol can be considered in pediatric patients for severe tics (Tourette syndrome) or acute agitation, typically after other options are ineffective. Dosing is weight-based and conservative, and specialist oversight (child and adolescent psychiatry or neurology) is strongly recommended. Monitor closely for EPS, sedation, and potential effects on growth and development. Always follow U.S. pediatric labeling and expert guidelines.
Geriatric use and dementia-related psychosis warning
Elderly patients are more sensitive to adverse effects, including orthostatic hypotension, sedation, EPS, and QT prolongation. In the United States, there is a boxed warning for increased mortality in elderly individuals with dementia-related psychosis treated with antipsychotic drugs. Haloperidol is not approved for this indication. If antipsychotics are considered for behavioral symptoms of dementia, clinicians weigh risks and benefits carefully, use nonpharmacologic strategies first, and prescribe the lowest dose for the shortest possible duration when necessary.
Safety information and monitoring
Before and during treatment, your prescriber may assess:
- Cardiac risk: baseline ECG if risk factors exist (personal or family history of long QT, syncope, electrolyte abnormalities, or use of other QT-prolonging medicines)
- Electrolytes: potassium and magnesium, especially if on diuretics or with GI losses
- Movement symptoms: screening for EPS and tardive dyskinesia at baseline and periodically
- Prolactin-related effects: monitor if symptoms occur (menstrual changes, galactorrhea)
- Hepatic function: consider LFTs in hepatic impairment or if signs of liver injury appear
Use caution if you have a history of seizures, severe cardiovascular disease, or significant hepatic impairment. Inform your clinician about all medical conditions and medications prior to starting haloperidol.
Recognizing serious risks
- Tardive dyskinesia (TD): involuntary, repetitive movements; risk increases with duration and cumulative dose. Consider periodic dose reduction and switch strategies as appropriate.
- Neuroleptic malignant syndrome (NMS): rare but life-threatening; characterized by high fever, muscle rigidity, altered mental status, and autonomic instability. Seek emergency care immediately if suspected.
- QT prolongation and torsades de pointes: risk increases with high doses, IV use (not an approved route for haloperidol in the U.S.), electrolyte disturbances, or interacting drugs. Report palpitations, syncope, or dizziness promptly.
Common and potential side effects
Side effects vary by dose, duration, and individual susceptibility. Not everyone experiences side effects, and many are manageable with dose adjustments or adjunctive therapy. Contact your clinician if any effect is severe or persistent.
Common
- Drowsiness or sedation
- Dry mouth, constipation, blurred vision (usually mild with haloperidol)
- Headache, dizziness, or restlessness
- Weight changes (generally modest compared with many atypical antipsychotics)
Extrapyramidal symptoms (EPS)
- Parkinsonism: stiffness, tremor, slowed movement
- Akathisia: inner restlessness, need to move
- Acute dystonia: painful muscle spasms, often of the neck or jaw (more common early in treatment)
Clinicians often manage EPS with dose reduction or adjunctive medications (e.g., anticholinergics or beta-blockers for akathisia). Report symptoms early.
Serious but less common
- Tardive dyskinesia (involuntary movements, potentially irreversible)
- Neuroleptic malignant syndrome (medical emergency)
- QT prolongation, arrhythmias, syncope
- Hyperprolactinemia (menstrual irregularities, galactorrhea, gynecomastia)
- Seizures (rare; caution in seizure disorders)
- Hepatic dysfunction (elevated liver enzymes, rare cholestatic jaundice)
When to seek urgent care
- Fainting, severe dizziness, or palpitations
- High fever, muscle rigidity, confusion, sweating (possible NMS)
- Severe allergic reaction: rash, hives, swelling of face/lips/tongue, breathing difficulty
Tourette syndrome and tics
Haloperidol can reduce the frequency and intensity of motor and vocal tics in Tourette syndrome, generally after other treatments (such as behavioral therapy or alternative medications) have proven insufficient. In Tourette syndrome, clinicians typically start with low doses (e.g., 0.5 mg/day) and increase cautiously to balance benefit and adverse effects. Ongoing monitoring for EPS and mood changes is required, and periodic attempts to reduce or discontinue therapy may be considered.
Managing severe agitation
In emergency or inpatient settings, short-acting IM haloperidol may be used to calm severe agitation associated with psychosis. U.S. protocols often combine de-escalation strategies with medication. Dosing is individualized, and vital signs are monitored closely. Because combining antipsychotics with benzodiazepines can increase sedation and respiratory risk, such combinations are used with caution and institutional safeguards.
Patient and caregiver strategies
- Maintain a written list of current medications and allergies.
- Attend follow-up appointments for dose adjustments and monitoring.
- Watch for early signs of EPS or cardiac symptoms and report them promptly.
Drug interactions with haloperidol
Haloperidol is metabolized by CYP3A4 and CYP2D6. Many medications can increase or decrease haloperidol levels, or add to the risk of QT prolongation or CNS depression. Always tell your clinician and pharmacist about every medicine and supplement you take, including over-the-counter products and herbal remedies.
Examples of interactions include:
- Strong CYP3A4 or CYP2D6 inhibitors (may increase haloperidol levels): ketoconazole, itraconazole, clarithromycin, ritonavir, fluoxetine, paroxetine, quinidine.
- CYP inducers (may decrease haloperidol levels): carbamazepine, rifampin, phenytoin, St. John’s wort.
- QT-prolonging drugs: amiodarone, sotalol, methadone, certain macrolide and fluoroquinolone antibiotics, other antipsychotics. Combining increases arrhythmia risk.
- CNS depressants: opioids, benzodiazepines, alcohol; additive sedation and respiratory depression are possible.
- Anticholinergics and antiparkinsonian agents: may be used to manage EPS but can increase anticholinergic burden.
This list is not exhaustive. Your healthcare team will help evaluate benefits and risks if combinations are clinically indicated.
Alcohol and haloperidol
Avoid alcohol while taking haloperidol due to additive sedation, impaired judgment, and increased risk of adverse events.
Contraindications and precautions
Do not use haloperidol if you have a known hypersensitivity to haloperidol or any formulation component. Haloperidol is contraindicated in patients with significant QT prolongation, congenital long QT syndrome, or a history of torsades de pointes. Use extreme caution in patients with Parkinson’s disease or Lewy body dementia due to severe sensitivity reactions, including profound extrapyramidal effects and confusion. In severe hepatic impairment, careful dose selection and monitoring are necessary.
Driving and operating machinery
Haloperidol may cause drowsiness, dizziness, or visual disturbances. Do not drive or operate heavy machinery until you know how the medicine affects you.
Pregnancy and breastfeeding
Data from observational studies suggest that first-generation antipsychotics, including haloperidol, have not been associated with a significant increase in major congenital malformations; however, all antipsychotics may pose risks such as neonatal EPS or withdrawal symptoms when used in the third trimester. Treatment decisions during pregnancy should involve a careful discussion between the patient and clinician, weighing maternal mental health needs and potential fetal risks. If used near delivery, monitor newborns for agitation, abnormal muscle tone, or feeding difficulties.
Haloperidol is excreted into breast milk. Breastfeeding while on haloperidol requires individualized assessment; clinicians consider maternal dose, infant monitoring for sedation or feeding issues, and alternative therapies. Do not start or stop medication during pregnancy or lactation without professional guidance.
How to take Haldol: pharmacist’s tips
Follow the exact dosing schedule provided by your U.S. prescriber. If you are prescribed tablets, take them consistently at the same time each day. The oral solution allows fine-tuning of small doses; measure carefully using a marked device. For long-acting injections, keep your clinic appointments on schedule to prevent symptom recurrence. Never adjust your dose or stop suddenly without medical advice; abrupt discontinuation can lead to relapse or withdrawal-like symptoms such as nausea, insomnia, and return of agitation or psychosis.
- If you miss a dose of the tablet or solution, take it as soon as you remember unless it’s close to your next dose. Do not double up.
- For decanoate injections, contact your clinic to reschedule missed appointments as soon as possible.
- Stay hydrated and rise slowly from sitting or lying positions to minimize dizziness.
- Report movement symptoms early; prompt management can prevent complications.
Monitoring plan
Your clinician may schedule periodic checks for movement disorders (EPS/TD), ECGs if indicated, and assessments of mental status, sleep, and functioning. Keep a symptom and side-effect diary to share at follow-ups.
Allergic reactions and emergencies
Seek immediate medical help if you develop swelling of the face, lips, tongue, or throat, difficulty breathing, or severe rash. Go to the emergency department if you suspect NMS (high fever, muscle rigidity, confusion) or experience fainting or palpitations.
Reporting side effects
If you experience any side effects, contact your prescriber or pharmacist promptly. You can also report adverse events to the FDA MedWatch program in the United States.
Frequently asked questions (FAQ)
How long does it take for Haldol to work?
Some symptoms such as severe agitation may respond within minutes to hours with IM dosing. With oral therapy, improvement in positive psychotic symptoms can begin within several days, with fuller effects over 2–6 weeks. Long-acting injections achieve steady control after the first 1–2 doses with oral overlap as needed.
Is Haldol better than atypical antipsychotics?
Effectiveness varies by individual. Haloperidol is potent for positive symptoms and acute agitation, with relatively low metabolic burden but higher risk of EPS/TD compared with many atypicals. Medication selection balances efficacy, side-effect profiles, comorbidities, and prior treatment response.
Can I drink coffee while taking haloperidol?
Caffeine is generally permissible, but large amounts can worsen anxiety or insomnia. Moderate intake and consistent daily patterns help avoid fluctuations that may affect sleep or restlessness.
What if I need surgery or a new medication?
Inform every clinician—including dentists and surgeons—that you take haloperidol. Some anesthetics, antibiotics, or antiarrhythmics may interact. Your team will plan safe perioperative management.
Recommendations from our specialists
For U.S. patients, the safest path to Haldol therapy is through a licensed prescriber who can provide an accurate diagnosis, select an appropriate formulation, and monitor for side effects. If you struggle with access, consider telehealth options in your state, ask about generics and 90-day supplies, and discuss long-acting formulations to support adherence. Never obtain haloperidol from unverified sources or use it without medical supervision.
Ready to support your treatment plan? Order Haldol with a valid U.S. prescription
Work with your clinician to determine whether haloperidol is right for you, then choose a licensed U.S. pharmacy or mail-order service for convenient, discreet delivery.
- Prescription required in the United States — evaluation by a licensed clinician ensures safe, appropriate use
- Fast, secure shipping via licensed U.S. mail-order pharmacies, where available
- Genuine medication sourced from FDA-regulated supply chains
- Multiple dosage forms (tablets, oral solution, short-acting IM, long-acting decanoate) tailored to your plan
- Supportive care — pharmacists and clinicians available to answer questions
Join patients nationwide who rely on licensed U.S. pharmacies for safe access to antipsychotic therapy. Discuss options with your prescriber today.
Contact Us
Address: Ponce de Leon Avenue, Indianapolis, 86398, USA
Phone: +1 351-792-5428
Opening Hours: 24/7 Online Service